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Memory and synaptic plasticity 
are impaired by dysregulated 
hippocampal O-GlcNAcylation
Yong Ryoul Yang1,2,*, Seungju Song3,4,*, Hongik Hwang3, Jung Hoon Jung5, Su-Jeong Kim5, 
Sora Yoon1, Jin-Hoe Hur1, Jae-Il Park6, Cheol Lee1, Dougu Nam1, Young-Kyo Seo1,  
Joung-Hun Kim5, Hyewhon Rhim3,4 & Pann-Ghill Suh1
O-GlcNAcylated proteins are abundant in the brain and are associated with neuronal functions and 
neurodegenerative diseases. Although several studies have reported the effects of aberrant regulation 
of O-GlcNAcylation on brain function, the roles of O-GlcNAcylation in synaptic function remain unclear. 
To understand the effect of aberrant O-GlcNAcylation on the brain, we used Oga+/− mice which have an 
increased level of O-GlcNAcylation, and found that Oga+/− mice exhibited impaired spatial learning and 
memory. Consistent with this result, Oga+/− mice showed a defect in hippocampal synaptic plasticity. 
Oga heterozygosity causes impairment of both long-term potentiation and long-term depression due 
to dysregulation of AMPA receptor phosphorylation. These results demonstrate a role for hyper-O-
GlcNAcylation in learning and memory.
O-GlcNAcylation is a posttranslational modification involving attachment of beta-N-acetylglucosamine (GlcNAc) 
to Ser/Thr residues. The addition and removal of O-GlcNAc to target proteins is regulated by O-GlcNAc transferase 
(OGT) and O-GlcNAcase (OGA), respectively1, and both OGT and OGA are abundantly expressed in the brain2,3. 
The roles of O-GlcNAcylation have been extensively investigated in aging-associated neurodegenerative diseases, 
such as Alzheimer’s disease and Parkinson’s disease4,5. Several aggregation-prone proteins involved in neurode-
generation are O-GlcNAcylated, including Tau6,7 and α -synuclein8,9. Elevated O-GlcNAcylation prevents protein 
aggregation and slows neurodegeneration4,5. β -amyloid precursor protein (APP) involved in amyloid plaque for-
mation is also O-GlcNAcylated10. Increased total O-GlcNAcylation attenuates the production of oligomeric Aβ 
, the main component of senile plaques, by lowering the activity of γ -secretase11. Oligomeric forms of amyloid-β 
(Aβ ) are known to acutely increase excitatory synaptic transmission and interfere with synaptic plasticity12,13. 
Previous evidence suggests that aberrant regulation of O-GlcNAcylation may contribute to the impaired synaptic 
plasticity in neurodegeneration.
O-GlcNAcylation is particularly enriched in neuronal synapses14,15, and proteomic studies have identified 
many postsynaptic density proteins modified by O-GlcNAc8,16. In addition, the activity of the brain OGT is 
ten-fold higher than that of peripheral tissues2. Various neuronal proteins are O-GlcNAcylated and involved 
in synaptic functions1,17. GluA2, a subunit of glutamatergic α -amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionate (AMPA) receptors, interacts with OGT, and is O-GlcNAcylated. Although phosphorylation of GluA2 
is not affected by increased O-GlcNAcylation, O-GlcNAcylation of GluA2 is required for synaptic plasticity18. 
Furthermore, synapsin I, a synaptic vesicle-associated protein, is O-GlcNAcylated, with suggested roles in the 
localization and function of synapsin I19,20. O-GlcNAcylation of synapsin I has been implicated in the modu-
lation of synaptic plasticity. In addition, O-GlcNAcylation is present on proteins important for neuronal sig-
naling. Calcium/calmodulin-dependent kinase II (CaMKII), CaMKIV, and the transcription factor cyclic 
adenosine monophosphate (AMP)–response element binding protein (CREB) are O-GlcNAcylated, which 
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influences synaptic plasticity in the hippocampus21–23. Although it is clear that O-GlcNAcylation is abundant 
in synapses and that O-GlcNAcylation affects synaptic plasticity and learning and memory in the hippocam-
pus, past studies have used different methods to modulate O-GlcNAcylation levels, resulting in conflicting 
results. Decreased O-GlcNAc levels by alloxan treatment (OGT inhibitor) impairs high-frequency stimulation 
(HFS)-induced long-term potentiation (LTP) in the Schaffer Collateral (SC)-CA1 Pathway24. In contrast, the ele-
vation of O-GlcNAcylation induced by Thiamet-G (OGA inhibitor) inhibits HFS-LTP and impairs hippocampal 
learning18.
Here we assessed how chronic elevations of O-GlcNAcylation in the hippocampus affect synaptic function, 
behavioral traits, and spatial learning and memory, using Oga+/− mice with constitutively increased O-GlcNAc 
levels.
Results
Oga+/− brains have normal morphology and dendritic spine density. Consistent with previous 
studies showing enriched expression of O-GlcNAc cycling enzymes, OGT and OGA, we detected high levels of 
O-GlcNAcase expression in the hippocampus, which was visualized by beta galactosidase (LacZ) staining of an 
Oga+/− brain section (Fig. 1a). To assess the effect of increased O-GlcNAcylation on hippocampus-dependent 
function, we used Oga+/− mice with chronically elevated O-GlcNAcylation. The hippocampal lysates prepared 
from Oga+/− mice showed an increase in the overall O-GlcNAcylation levels (Fig. 1b). To verify the elevation of 
O-GlcNAcylation in the hippocampus, we used immunohistochemistry with an anti-O-GlcNAc antibody. As 
expected, increased immunoreactivity was observed throughout all regions of the hippocampus in Oga+/− mice 
compared to WT. (Fig. 1c). Next, we tested whether Oga heterozygosity leads to morphological changes in the 
brain. Morphological analysis of neurons in the hippocampus by Nissl staining revealed that the Oga+/− hip-
pocampus shows no morphological changes in hippocampal CA1, CA3, or dentate gyrus (DG) (Fig. 1d). In 
addition, we found that there were no differences in the numbers of cells immunostained for the neuronal marker 
neuronal nuclei (NeuN) and for the astrocyte marker glial fibrillary acidic protein (GFAP) in the hippocampal 
CA1, CA3, or DG (Fig. 1e). The average brain weight also was not affected by Oga heterozygosity (Fig. 1f and g). 
Lastly, dendritic spine density was not altered in the Oga+/− hippocampal CA1 pyramidal neurons (Fig. 1h and i). 
These results together suggest that synaptic development and hippocampal structure are not affected by the ele-
vation of O-GlcNAcylation.
Oga+/− mice display impaired spatial learning and memory. Various neuronal proteins involved 
in synaptic function and learning and memory are known to be O-GlcNAcylated8,9,15. To assess whether 
hyper-O-GlcNAcylation affects hippocampal-dependent spatial learning and memory, we employed the Barnes 
circular maze test. In this test, mice were trained to escape a brightly lighted circular field by discovering the 
escape hole at its periphery. Compared with wild-type (WT) mice, Oga+/−mice showed impaired learning perfor-
mance during four days of training (Fig. 2a–c). To assess memory formation, we performed probe trials on days 
5 and 12. WT and Oga+/−mice performed similarly during the probe trials when total distance was measured 
(Fig. 2d and g). Oga+/− mice exhibited increased latency to the target region during probe trials (Fig. 2f and i). 
However, no significant difference were observed in the time spent in the target region between WT and Oga+/− 
mice (Fig. 2e and h). To further verify the impairment in spatial learning and memory of Oga+/− mice, we per-
formed a context fear conditioning test. Compared with WT mice, Oga+/− mice failed to retain fear memory 24 h 
after fear conditioning (Fig. 2j and k). Our data indicate that proper removal of O-GlcNAc modification by OGA 
is required for hippocampal-dependent spatial learning and memory.
To examine motor coordination in these mice, we tested motor performance using the rotarod task. Oga+/− 
mice did not display a defect in motor function during the rotarod test (Fig. S1A). During the open field test, 
Oga+/− mice showed normal locomotor activities (Fig. S1B and C). Anxiety-related behaviors were also tested 
using the elevated plus maze. Compared with WT mice, Oga+/− mice exhibited no significant differences in the 
number of entries to the open arms and amount of time spent in the open arms (Fig. S1D–G). Considered collec-
tively, these data indicate that Oga+/− mice show normal locomotor activity and anxiety levels.
Glutamatergic and GABAergic synaptic transmission in the hippocampus is normal in Oga+/− 
mice. We next explored the effect of heterozygous loss of Oga on intrinsic neuronal excitability and excit-
atory synaptic transmission in hippocampal CA1 pyramidal neurons. Excitability was tested by injecting step 
depolarizing currents, and we found that intrinsic excitability of hippocampal CA1 pyramidal neurons remains 
unchanged in Oga+/− mice (Fig. 3a and b). The frequency and amplitude of miniature excitatory and inhibitory 
postsynaptic currents (mEPSCs and mIPSCs, respectively) in hippocampal CA1 pyramidal neurons were also 
comparable in WT and Oga+/− pyramidal neurons (Fig. 3c and d), indicating that basal synaptic responses are 
not affected in Oga+/− mice. In addition, we measured the ratio of AMPA to N-methyl-D-aspartate (NMDA) 
receptor-mediated synaptic currents in SC− CA1 synapses, and the AMPA/NMDA ratio was similar between 
WT and Oga+/− synapses (Fig. 3e). These results suggest that Oga heterozygosity does not affect basal SC− CA1 
synaptic transmission or short-term plasticity.
Impaired NMDA receptor (NMDAR)-dependent synaptic plasticity in Oga+/− mice. Previous 
studies investigating the effects of increased O-GlcNAcylation on synaptic plasticity have generated conflicting 
results18,24. Therefore, we next assessed whether increased O-GlcNAcylation resulting from Oga haploinsuffi-
ciency alters synaptic plasticity. The slope of the field excitatory postsynaptic potential (fEPSP) to fiber volley 
amplitudes (input-output curves) was not changed in Oga+/− mice (Fig. 4a). Presynaptic release probability, as 
measured by paired-pulse facilitation (PPF), also remained unaffected in Oga+/− mice (Fig. 4b). When we meas-
ured NMDAR-mediated LTP in Oga+/− mice, the magnitude of LTP induced by high-frequency stimulation 
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(HFS) at the SC− CA1 pathway was reduced compared to WT mice (Fig. 4c). Moreover, in the same hippocampal 
pathway, low-frequency stimulation (LFS)-induced long-term depression (LTD) was impaired in Oga+/− mice in 
comparison to WT mice (Fig. 4d). These results suggest that the removal of O-GlcNAcylation mediated by OGA 
is required for NMDAR-dependent LTP and LTD at SC− CA1 synapses.
Impaired modulation of AMPA receptor during LTP/LTD in Oga+/− mice. Regulation of AMPA 
receptor trafficking is crucial for controlling the strength of synaptic transmission during LTP/LTD. In particu-
lar, phosphorylation of GluA1 AMPAR subunit at S845 and S831 play key roles in AMPA receptor trafficking 
and synaptic plasticity25. We thus decided to examine whether GluA1 phosphorylation is altered in response to 
chemically induced LTP and LTD in Oga+/− hippocampus. We briefly stimulated hippocampal slices from WT 
Figure 1. Normal morphological features and dendritic spine density in Oga+/− brains (a) Beta galactosidase 
(LacZ) staining of the Oga+/− adult brain, confirming the expression pattern of OGA in the hippocampus. 
Scale bar, 200 μ m. (b) Immunoblot analysis showing elevated O-GlcNAcylation in Oga+/− hippocampal lysates 
compared with that in the WT hippocampal lysates. (c) Representative images of hippocampal neurons from 
WT and Oga+/− mice immunolabeled for O-GlcNAc (green). Scale bar, 200 μ m. (d) Nissl staining of the 
hippocampus from coronal brain sections. Scale bar, 100 μ m. (e) Immunostaining for a neuronal cell marker 
(neuronal nuclei; NeuN), glial marker (glial fibrillary acidic protein; GFAP), and nuclei (4′ ,6-diamidino-2-
phenylindole; DAPI) in the hippocampus of WT and Oga+/− mice at eight weeks of age. Three sections were 
obtained from three mice. Scale bar, 100 μ m. (f) Representative pictures of brain tissues. (g) Whole-brain 
weight (without skull) isolated from the WT and Oga+/− mice at eight weeks of age (n = 5). (h) Representative 
images of dendritic segments of Golgi-stained CA1 pyramidal neurons from WT and Oga+/− mice (scale 
bar = 10 μ m) (i) Spine number was quantified along a 10 μ m segment from the primary apical dendritic branch 
origin of Golgi-impregnated CA1 pyramidal neurons (n = 15–20 dendrites from three mice). Error bars 
represent ± standard error of the mean (SEM). NS: not significant (unpaired t-test). Full-length blots/gels are 
presented in Supplementary Figure S4.
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and Oga+/− mice with glycine for LTP or NMDA for LTD26,27. WT hippocampal slices showed elevated phospho-
rylation of the S845 and S831 GluA1 in chemical LTP, and the phosphorylation of the S845 GluA1 was decreased 
in chemical LTD. However, in Oga+/− hippocampal slices, phosphorylation of the S845 and S831 GluA1 were not 
properly regulated following chemical LTP or LTD (Fig. 5a–c). These results indicate that Oga heterozygosity 
impairs the proper regulation of AMPA receptor phosphorylation during synaptic plasticity.
Diverse neuronal proteins and signaling mediators are O-GlcNAcylated and involved in synaptic functions. 
For example, AMPA receptor subunit GluA2 is O-GlcNAcylated by OGT18, and CaMKII, CaMKIV, and CREB 
whose alternation of activity affects synaptic plasticity28,29, are also O-GlcNAcylated21–23. Oga heterozygosity did 
not alter the basal phosphorylation or total protein levels AMPA receptor subunits (GluA1, GluA2) and NMDA 
receptor subunits (GluN1, Glun2A, GluN2B) (Fig. S2A). In addition, no difference was observed in phosphoryl-
ation of CaMKII, CaMKIV, or CREB between the hippocampus of WT and Oga+/− mice (Fig. S2B).
Discussion
Although increasing evidence has been generated by various studies regarding the significance of 
O-GlcNAcylation in regulating synaptic functions, the different experimental designs used have resulted in con-
flicting conclusions on the impact of changing the levels of O-GlcNAcylation. Here we used mice with a hete-
rozygous loss-of-function mutation in OGA which have elevated O-GlcNAc levels. We found that OGA is highly 
expressed in the hippocampus, suggesting that O-GlcNAc modification of neuronal proteins is closely related to 
hippocampus-dependent functions. Oga+/− mice exhibited impaired synaptic plasticity in the hippocampus at 
SC-CA1 synapses, dysregulated phosphorylation of AMPA receptor subunit GluA1 in chemically induced LTP 
Figure 2. Spatial learning memory deficits in Oga+/− mice (a) Latency in attaining the goal and (b) number of 
errors committed before reaching the goal in the Barnes maze task. (WT, n = 9; Oga+/−, n = 9, one-way ANOVA 
followed by the Tukey’s test to unpaired t-test) (c) Representative traces of WT and Oga+/− mice in the Barnes 
maze task. (d) Total distance, (e) time spent in the target area, and (f) time of latency to attaining the target hole 
during a probe trial on day 5. (g) Total distance, (h) time spent in the target area, and (i) time of latency to attain 
the target hole during a probe trial on day 12. (WT, n = 9; Oga+/−, n = 9) (j) Schematic diagram of the context-
dependent fear conditioning procedure (k) Percentage time freezing during the 3 min of the context test 24 h 
after fear conditioning. (WT, n = 9; Oga+/−, n = 8). Error bars represent ± standard error of the mean (SEM). 
NS: not significant, ***P < 0.001, **P < 0.01, *P < 0.05 (unpaired t-test).
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and LTD, and deficits in hippocampus-dependent learning and memory. This result together demonstrates that 
increased levels of O-GlcNAcylation lead to altered synaptic plasticity in the hippocampus, which may underlie 
the impairment of learning and memory observed in Oga+/− mice.
Several studies have shown that synaptic plasticity is variably affected by O-GlcNAcylation. Tallent et al. showed 
that the elevation of O-GlcNAcylation induced by OGA inhibitor (9d) decreases PPF and increases LTP induction, 
and suggested that the elevation of O-GlcNAcylation facilitated LTP by modulating the interplay between phospho-
rylation and O-GlcNAcylation of signaling molecules, such as synapsin I/II, ERK, and CaMKII24. In the same study, 
the authors also reported that reduced O-GlcNAcylation with OGT inhibitor (Alloxan) prevents LTP induction24. 
However, contrary to this result, Kanno et al. found that Alloxan enhances hippocampal SC-CA1 LTP by regulat-
ing AMPA receptor trafficking30. Taylor et al. also showed that acutely elevated O-GlcNAcylation by OGA inhibitor 
(Thiamet-G) or glucosamine induces LTD, but impairs LTP at CA3-CA1 synapses, which also led to a deficit in novel 
object recognition18. Each study mentioned above used different methods to change the levels of O-GlcNAcylation. 
Alloxan is known as a weak OGT inhibitor and thus likely to have off-target effects31,32. Furthermore, as we previ-
ously reported, the OGA inhibitor (Thiamet-G) increases the levels of OGA expression33,34. Glucosamine also affects 
Figure 3. Normal synaptic transmission in Oga+/− mice. (a) Representative traces of action potentials 
triggered by − 100–200 pA current injection in the hippocampal CA1 region of WT and Oga+/− mice.  
(b) Number of action potentials trigged by the injection of current at different levels (WT, n = 11; Oga+/−, 
n = 9; unpaired t-test, not significant) (c) Representative mEPSC traces from WT and Oga+/− hippocampal 
CA1 pyramidal neurons (upper). Average values for mEPSC amplitude (lower left) and frequency (lower right) 
(WT, n = 9; Oga+/−, n = 10; unpaired t-test, NS: not significant) (d) Representative mIPSC traces from WT and 
Oga+/− hippocampal CA1 pyramidal neurons (upper). Average values for mIPSC amplitude (lower left) and 
frequency (lower right). (WT, n = 10; Oga+/−, n = 8; unpaired t-test, NS: not significant) (e) AMPA/NMDA 
current ratio (WT, n = 20; Oga+/−, n = 17; Mann-Whitney U test, NS: not significant).
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various intracellular signaling pathways35–37. Each experiment was performed in acutely elevated O-GlcNAcylation 
by pretreatment of OGA inhibitors or glucosamine. The different experimental designs might have resulted in con-
flicting results. Previously, the discrepancy in the effect of dysregulated O-GlcNAcylation was also observed in other 
intracellular signaling pathways and physiological functions33,34,38. Despite this discrepancy, earlier studies suggest 
that dysregulated O-GlcNAcylation can affect synaptic plasticity. Here, we used OGA heterozygous mice that have 
elevated O-GlcNAcylation levels. Oga+/− hippocampus displayed impaired regulation of AMPAR GluA1 phospho-
rylation which plays an important role in mediating AMPAR trafficking during synaptic plasticity. Although Taylor 
et al. showed that GluA1 is not O-GlcNAcylated18, the phosphorylation of GluA1 can be indirectly regulated by acti-
vation of upstream signaling molecules, including protein kinase C (PKC), CaMKII, and protein kinase A (PKA)39–41. 
Importantly, both PKC and CaMKII are modified by O-GlcNAcylation21,42, and the dynamic interplay between 
O-GlcNAcylation and phosphorylation in neurons was shown to be involved in hippocampal synaptic plasyticity24. 
Activation of PKC or PKA reduces global O-GlcNAc levels in cytoskeletal fraction of cultured cerebellar neurons43. We 
speculate that GluA1 phosphorylation might be affected by altered O-GlcNAcylation levels. However, we cannot rule 
out the possibility that Oga heterozygosity affects multiple signaling pathways involved in hippocampal LTP and LTD.
ROS play an important role in synaptic plasticity44 by regulating synaptic plasticity-related signaling mole-
cules, receptors, and channels45–47. Importantly, O-GlcNAcylation have been shown to affect ROS generation48. 
In addition, forkhed box O1 (FoxO1), a regulator of the transcription of the oxidative stress responsive enzymes 
catalase and MnSOD (SOD2), is O-GlcNAcylated49. We therefore examined whether ROS levels are affected in 
Oga+/− hippocampus compared to WT hippocampus. Despite Oga heterozygosity, the ROS levels were not altered 
in Oga+/− hippocampus (Fig. S3).
Aging is associated with impairments in cognitive and synaptic function50. Dysfunction of the aging brain is 
not caused by neuronal loss51 but by specific alterations in neuronal morphology, cell-cell interactions, and gene 
expression50. The hippocampus appears to be particularly vulnerable to the effects of aging on cognitive func-
tion and synaptic plasticity. O-GlcNAcylation and its regulatory enzymes are highly detected in the hippocam-
pus52. O-GlcNAcylation modulates neuronal cell signaling processes and gene expression, which is critical for 
Figure 4. Impaired long-term potentiation (LTP) and long-term depression (LTD) in Oga+/− mice.  
(a) Input-output curves for basal synaptic transmission in area CA1 of the hippocampus. Representative traces 
are shown for the input (fiber volley) and the output (field excitatory postsynaptic potential; fEPSP). (WT, 
n = 9; Oga+/−, n = 10; unpaired t-test, not significant) (b) Paired-pulse facilitation (PPF) in WT and Oga+/− 
hippocampal CA1 pyramidal neurons. Representative traces from WT and Oga+/− at 50 ms interstimulus 
interval are shown. (WT, n = 8; Oga+/−, n = 10; unpaired t-test, not significant) (c) High frequency stimulation 
(HFS)-induced LTP (WT, n = 10; Oga+/−, n = 9). Traces show averaged fEPSP indicated with 1 and 2. A bar 
graph is depicted 50 min after LTP. (d) LFS-induced LTD (WT, n = 7; Oga+/−, n = 8). Traces show averaged 
fEPSP indicated with 1 and 2. A bar graph is depicted 50 min after LTD. Error bars represent ± standard error of 
the mean (SEM). ***P < 0.001 (unpaired t-test).
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proper neuronal function1,53. Interestingly, we previously reported that the brains of older mice show significantly 
increased levels of O-GlcNAcylation compared with those in younger mice3. However, the mechanism underly-
ing the chronic elevations in O-GlcNAcylation on brain aging remains unknown. Based on our observations, in 
the normally aged brain, we speculate that chronically elevated O-GlcNAcylation contributes to impairment of 
synaptic plasticity and learning and memory.
Methods
Mice. Oga+/− mice (C57BL/6J) were generated as described previously3. All mice were housed under a 
12-hour light/dark cycle and given ad libitum access to food and water. All experimental protocols were approved 
by Institutional Animal Care and Use Committee of the Ulsan National Institute of Science and Technology 
(UNISTIACUC-14–018) and all methods were performed in accordance with the relevant guidelines and regulations.
Barnes maze. The paradigm of Barnes circular maze consists of white circular platform (92 cm diameter), 
with 20 evenly spaced holes (5 cm diameter) located 7.5 cm from the perimeter and is elevated 100 cm above the 
floor. Several spatial cues with distinct shapes were placed near the walls of the testing room. A black target box 
(20 × 10 × 10 cm) was placed under one hole. The mice were encouraged to find this box by aversive noise (85 dB) 
on the platform. Barnes maze were run for 4 consecutive days, and 3 trials were carried out each day with 20 min 
inter-trial intervals. The mouse was allowed to search for the target box for 3 min. Distance, latency, and numbers 
of errors to reach the target hole were recorded during training trials by video tracking software. On day 5, a 
probe test was performed without the escape box. Mice were allowed to freely find the target box for 3 min. Time 
spent around each hole, total distance travelled, and the latency to find target hole were recorded.
Golgi staining. Brains from 8-week-old mice were processed with the FD Rapid GolgiStain™ Kit 
(NeuroTechnologies) according to the instructions of the manufacturer. Images of dendritic spines (apical 
dendrites of CA1 pyramidal neurons) were acquired using an Olympus Cell^TIRF Xcellence microscope in 
UNIST-Olympus Biomed Imaging Center (UOBC).
Chemical LTP and LTD induction. Acute hippocampal slices (300-μ m thick) from WT or Oga+/− mice 
(8–10 weeks) were prepared in a sucrose-cutting buffer containing (in mM) 234 sucrose, 2.5 KCl, 1.25 NaH2PO4, 
Figure 5. Deficit in chemically induced LTP and LTD in Oga+/− mice. (a) Representative immunoblots 
showing effects of chemical LTP and LTD induction on AMPAR subunits GluA1 S845, S831 phosphorylation. 
Acute hippocampal slices were stimulated with either glycine (200 μ M) for chemical LTP or NMDA (20 μ M) for 
chemical LTD. Levels of phospho-S845 and phospho-S831 of GluA1, and levels of total O-GlcNAc-modified 
proteins were analyzed by immunoblotting. (b) Chemical LTP and LTD significantly increases and decreases 
the levels of GluA1 S845 phosphorylation, respectively in WT (n = 4, normalized to control). However, acute 
hippocampal slices from Oga+/− mice failed to exhibit a significant change in GluA1 S845 phosphorylation 
following chemical LTP and LTD induction (n = 3, normalized to control). One-way ANOVA followed by 
the Tukey’s test was used. (c) Chemical LTP significantly increases the levels of GluA1 S831 phosphorylation 
in WT (n = 3, normalized to control), but not in Oga+/− mice (n = 3, normalized to control). Error bars 
represent ± standard error of the mean (SEM). NS: not significant, *p < 0.05, **p < 0.01, ***p < 0.001; one-way 
ANOVA followed by the Tukey’s test. Full-length blots/gels are presented in Supplementary Figure S4.
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24 NaHCO3, 11 glucose, 10 MgSO4, 0.5 CaCl2 bubbled with 95% O2 and 5% CO2. The slices were recovered at 
35 °C for one hour in a recovery buffer containing (in mM) 124 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 10 
glucose, 6.5 MgSO4, 1 CaCl2 bubbled with 95% O2 and 5% CO2. Following the recovery, the slices were further 
incubated at 37 °C for one hour in an extracellular fluid containing (in mM) 125 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2, 
33 glucose, 25 HEPES, and then treated with 20 μ M D-AP5 and 0.5 μ M TTX for 20 min. The slices were subse-
quently treated with 3 μ M strychnine, 20 μ M bicuculline and 200 μ M glycine for 10 min to induce chemical LTP, 
or with 20 μ M NMDA for 3 min to induce chemical LTD in a Mg-free extracellular fluid, and transferred back to 
a regular extracellular fluid for 30 min prior to sample collection.
Statistical analysis. The Student’s unpaired T-test or non-parametric Mann–Whitney U-test was used to 
compare two independent groups. For multiple comparisons, a one-way repeated measures ANOVA with Tukey’s 
post hoc test was utilized, as specified in the Figure legends. All data are expressed as the mean ± SEM and signif-
icance indicated by *P < 0.05, **P < 0.01, and ***P < 0.001.
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